Trials / Sponsors / Quratis Inc.
Quratis Inc.
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74 Tuberculosis, Pulmonary | Phase 1 | 2025-05-09 |
| Unknown | Study to Assess Safety, Reactogenicity and Immunogenicity of the repRNA(QTP104) Vaccine Against SARS-CoV-2(COV COVID-19, SARS-CoV-2 | Phase 1 | 2021-11-19 |
| Unknown | Phase 1 Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Adolescent Tuberculosis | Phase 1 | 2019-04-02 |
| Unknown | Phase 2a Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Healthcare Workers Tuberculosis | Phase 2 | 2018-05-31 |